Mibe GmbH Arzneimittel - Company Review
Mibe GmbH Arzneimittel - Company ReviewSummary
Mibe GmbH Arzneimittel (MIBE), a subsidiary of Dermapharm AG is a drug company that manufactures and develops therapeutic products. The company's products include pain killers, disinfectants, wound healing agents, cardiovascular preparations, asthma agents, gastrointestinal agents, vitamins and medicines for the treatment of cancer. It provides ophthalmological agents, local anesthetics and preparations for bone metabolism. MIBE offers products in dosage forms of liquid, fixed, semi solid and other dosage forms include pavement, sprays, shaking mixtures, oil and inhalants. Its product is used for eye disorders, osteoporosis, rheumatism and pain, thyroid disease, acid-related diseases, vitamins, and vein problems. MIBE is headquartered in Brehna, Germany.
This comprehensive company report of Mibe GmbH Arzneimittel provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.